Su, X.; Huang, Z.; Xu, W.; Wang, Q.; Xing, L.; Lu, L.; Jiang, S.; Xia, S.
IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies. Biomolecules 2023, 13, 1283.
https://doi.org/10.3390/biom13091283
AMA Style
Su X, Huang Z, Xu W, Wang Q, Xing L, Lu L, Jiang S, Xia S.
IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies. Biomolecules. 2023; 13(9):1283.
https://doi.org/10.3390/biom13091283
Chicago/Turabian Style
Su, Xiaojie, Ziqi Huang, Wei Xu, Qian Wang, Lixiao Xing, Lu Lu, Shibo Jiang, and Shuai Xia.
2023. "IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies" Biomolecules 13, no. 9: 1283.
https://doi.org/10.3390/biom13091283
APA Style
Su, X., Huang, Z., Xu, W., Wang, Q., Xing, L., Lu, L., Jiang, S., & Xia, S.
(2023). IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies. Biomolecules, 13(9), 1283.
https://doi.org/10.3390/biom13091283
_Kwok.png)
